Sunil V Badve

5PUBLICATIONS
30CO-AUTHORS
PharmacogenomicsMolecular targetsCharacterisation of biological macromoleculesNeurology and neuromuscular diseases
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Sep 30, 2026
Semaglutide in type 2 diabetes and chronic kidney disease in Australia: practical clinical considerations from a multidisciplinary panel.

|Mar 29, 2025
Cardiovascular and Kidney Outcomes and Mortality With Long-Acting Injectable and Oral Glucagon-Like Peptide 1 Receptor Agonists in Individuals With Type 2 Diabetes: A Systematic Review and Meta-analysis of Randomized Trials.

Matthew M Y Lee, Naveed Sattar, Rodica Pop-Busui

|Aug 30, 2024
Cardiovascular, Kidney, and Safety Outcomes With GLP-1 Receptor Agonists Alone and in Combination With SGLT2 Inhibitors in Type 2 Diabetes: A Systematic Review and Meta-Analysis.

Brendon L Neuen, Robert A Fletcher, Lauren Heath

|Dec 03, 2020
The effects of dipeptidyl peptidase-4 inhibitors on kidney outcomes.

Daniel V O'Hara, Thomas R Parkhill, Sunil V Badve

|Jun 25, 2020
Effects of Allopurinol on the Progression of Chronic Kidney Disease.

Sunil V Badve, Elaine M Pascoe, Anushree Tiku

Pageof 1

Frequent Collaborators

3 joint publications

Vlado Perkovic

2 joint publications

Richard Pratley

1 joint publications

Eugenia Pedagogos

1 joint publications

Adam Nelson